Yüklüyor......
Immunoresponse to Gene-Modified Hematopoietic Stem Cells
Gene transfer to and correction of hematopoietic stem cells (HSCs) are ideal strategies to cure a number of congenital and acquired disorders. However, transgene products may trigger immunological rejection of modified cells, limiting their therapeutic benefits. Preclinical and clinical data indicat...
Kaydedildi:
| Yayımlandı: | Mol Ther Methods Clin Dev |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society of Gene & Cell Therapy
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6859277/ https://ncbi.nlm.nih.gov/pubmed/31763350 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2019.10.010 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|